Europe Pharmaceutical Drug Delivery Market

The report "Europe Pharmaceutical Drug Delivery Market By Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]-Forecast to 2031" The Europe pharmaceutical drug delivery market was estimated to be worth USD 519.6 million in 2026 and is poised to reach USD 703.2 million by 2031, growing at a CAGR of 6.2% from 2025 to 2031.

Browse 660 market data Tables and 60 Figures spread through 460 Pages and in-depth TOC on "Europe Pharmaceutical Drug Delivery Market By Route of Administration [Oral (Tablet, Capsule), Injector, Topical (Cream, Transdermal Patch), Transmucosal, Nasal], Application [Cancer, Diabetes], Care Setting [Hospital, Homecare]-Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-pharmaceutical-drug-delivery-market-148622116.html

The Europe pharmaceutical drug delivery market is rising due to increasing usage of biologics and biosimilars, growing prevalence of chronic illnesses, and a growing acceptance of emerging drug delivery devices such as auto-injectors, prefilled syringes, and inhalation drug delivery devices. Moreover, the increasing population of seniors, rising home care usage, and government support policies for patient-friendly drug delivery systems are also fueling this market. The key trends in this market are self-administration, technology-driven drug delivery, sustainable drug delivery, and drug device combinations.

The Europe market for pharmaceutical drug delivery faces various challenges, including complex regulatory requirements in different member nations, which can lead to prolonged approval times for drug-device combinations. The additional expenditures associated with advanced drug delivery technology and strict quality requirements pose a challenge for manufacturers. Budget constraints in healthcare further limit the widespread use of high-end delivery devices. Labor, value chain, and sustainability issues also continue to pose a challenge for manufacturers. The inclusion of connected drug delivery technology faces challenges related to security, compatibility, and reimbursement.  

By route of administration, the injectable drug delivery segment accounted for the largest market share in 2025.

By route of administration, injectables are projected to lead in 2025, driven by increasing Europe reliance on biologics and biosimilars for the treatment of cancer, autoimmune, and chronic diseases. These prefilled injectables, available in syringe, auto-injector, or pen form, remain popular due to their ease of use, precision, and portability. Moreover, increasing acceptance of patient self-administration, coupled with support for combination product development, further validates injectables as the most popular administration routes in Europe.

The autoimmune diseases segment is expected to account for the highest CAGR, by application in the Europe Pharmaceutical Drug Delivery Market.

The autoimmune diseases segment is the fastest-growing segment in applications within the EU from 2026 to 2031, driven by the increasing incidence of rheumatoid arthritis, psoriasis, and inflammatory bowel disease. With a growing pool of biologic and targeted therapies entering the market, many of which feature injectable or infusion-based delivery mechanisms, demand for advanced systems is also increasing. Better diagnosis and wider access to treatments, along with a trend toward self-injectable options in therapies, add to the higher demand for specialized drug delivery solutions in the care of autoimmune diseases.

By care setting, the hospitals segment has accounted for the largest market share in 2025.

By care setting, hospitals are anticipated to register the largest share in 2025 due to their high volume of acute care, infusion, and complex biologics that require monitoring. Hospitals in Europe benefit from a superior purchasing position in their markets and a preference for adopting advanced infusion pumps, injectable, and controlled delivery systems early. Increasing surgical volumes, cancer cases, and emergency care also solidify that drug delivery remains, for now, in a hospital setting despite the development of home healthcare options.

Key Market Players

Some of the prominent players operating in the APAC market include Johnson & Johnson Services, Inc. (US), Pfizer Inc. (US), Fresenius Kabi (Germany), Becton, Dickinson and Company (US), Nemera (France), B. Braun (Germany), Gerresheimer AG (Germany), SHL Medical (Switzerland), Novo Nordisk (Denmark), Novartis (Switzerland), Sanofi (France), Baxter International (US), AstraZeneca (United Kingdom), Roche (Switzerland), and medmix (Switzerland).

Don’t miss out on business opportunities in Europe Pharmaceutical Drug Delivery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/